Plain-English translation of NCT03152630 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying stroke patients to find early warning signs of dementia—specifically, changes in blood that might predict who will develop thinking and memory problems later on. This trial will collect blood samples from about 600 people to look for specific biological markers that could help doctors spot cognitive decline before it becomes serious.
After a stroke, some patients develop dementia within months or years, but there's currently no reliable way to predict who will be affected. This study aims to discover blood-based markers that could identify at-risk patients early, allowing doctors to provide better treatment and care before serious problems develop.
You likely qualify if…
You likely don't qualify if…
Participants will donate blood samples that researchers will analyze to look for biological markers linked to dementia risk. The study is still recruiting, so you would meet with the research team at National Taiwan University Hospital to discuss your medical history, provide consent, and have blood drawn for testing. The exact number and timing of visits will be determined by the research team.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Taiwan
~600 participants
Started
March 2016
Primary completion
January 2036
Age range
65 Years and older
Last updated on clinicaltrials.gov in May 2017.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chau C Wu, M.D., Ph.D.
National Taiwan University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.